Pharmaceutical global market access consultancy Valid Insight has been named as one of a select number of businesses to win the Queen’s Award for Enterprise: International Trade. The Queen’s Awards for Enterprise are the UK’s most esteemed business awards. Valid Insight, which provides expert consultancy services that guide clients in the pharmaceutical, biotech and medical device industry to global market access success, is to be honoured in recognition of its growth strategy. Since being established in 2016, the company has grown exponentially, with their international client base and sales expanding by almost 800% in the last three years. Valid Insight’s founder and Managing Director, Steve Bradshaw, who will attend a Royal Reception at Buckingham Palace in June hosted by HRH The Prince of Wales, commented: “We are honoured to receive the Queen’s Award for Enterprise in International Trade. We compete against a strong set of consultancy firms on a global level and to win this award means that what we are doing is world class”. Bradshaw added that the Queen’s Award “strengthens our reputation as a leader” and “will further encourage us to extend our high standard of expertise in the challenging area of pharmaceutical market access, helping more multinational companies bring better medicines to patients across the world”.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.